Navigation Links
PTS Diagnostics Announces New Wellness Brand

PTS Diagnostics, a U.S.-based manufacturer of point-of-care testing devices, today announced the upcoming global launch of PreVantage, an all-encompassing family of solutions and partnerships aimed at addressing the growing demand for the achievement of positive population health outcomes.

The PreVantage brand was developed to address the complex needs of the multiple markets served by PTS Diagnostics. These configurable solutions are offered under singular umbrella brand and can be customized based upon unique customer needs.

“This brand marks our transition into becoming a global wellness solutions provider,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “For more than two decades, PTS Diagnostics has partnered with leaders largely in the health industry by providing products such as our A1CNow® systems and CardioChek® analyzers, which can allow healthcare professionals to monitor diabetes, as well as assess cardiovascular disease risk. We anticipate using PreVantage to build upon these existing relationships, continue our rapid expansion into new markets, and to help shape the future of healthcare.”

PreVantage allows PTS Diagnostics to strategically align with global healthcare changes through a unique focus on patient outcomes, lower healthcare costs, and improved clinician and patient experiences.

“Outcomes are the new income in many healthcare models, and point-of-care testing aligns perfectly by rapidly and accurately providing results in minutes instead of days,” said Stephen Riendeau, Chief Commercial Officer of PTS Diagnostics. “In this complex global environment, no one product or company can meet the multitude of market demands, it will take an innovative approach which challenges the way that suppliers traditionally have partnered with customers. We’re hopeful that strategic partnerships associated with PreVantage will open doors in multiple market segments and help to improve the overall state of global healthcare.”

PreVantage is being unveiled in the United States and select countries in early 2019. It will continue to grow nationally as healthcare shifts from a fee-for-service model to merit-based incentivization. The brand will also mature globally as PTS Diagnostics assists with meeting unique healthcare needs abroad.

Interested parties are encouraged to reach out to PTS Diagnostics via phone at 877-870-5610, or email at customerservice(at) for more information.

About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 130 countries around the globe. For more information, visit


Press Contact:
Ryan Simpson, Senior Marketing Associate
317-870-5610 – rsimpson(at)

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related medicine news :

1. Preora Diagnostics’ Cancer Screening Platform Honored by Two Chicago Organizations
2. Development of Precision Cancer Diagnostics Continues Amid Booming Tumor Profiling Market
3. Dr. Esther Babady Discusses the Laboratory and Clinical Benefits of Rapid Blood Culture Diagnostics
4. Sandstone Diagnostics Announces Programs and Sponsorships Supporting Men’s Health Week 2017
5. Dymedix Diagnostics Completes Phase One Building a Global Distributor Network
6. SDGKC: Precision Medicine Poised to Change Brain Tumor Diagnostics and Treatment
7. Hardy Diagnostics Highlighted within Mediaplanet’s Newly Released “Fighting Infection” Campaign
8. Marker Test Diagnostics Enters Into Partnership with Atlantic Biotech Labs to Distribute UR Code™ Product
9. Acutis Diagnostics Announces Its Expansion
10. Slone Partners Places VP of North American Capital Sales at HTG Molecular Diagnostics
11. Advanced Cell Diagnostics Webinar on Surveying Expression of Immune Checkpoint Markers in Tissue Microenvironment
Post Your Comments:
(Date:2/13/2019)... ... 2019 , ... Diameter Health , the leader in clinical data normalization ... Management Act (FISMA) High General Support System Authority to Operate (ATO) for Diameter Health’s ... for the VA because of their work with confidential patient data. Protecting this data ...
(Date:2/13/2019)... ... ... Castle announced today that it has raised $9.2M in Series A funding from ... First Round and F-Prime Capital Partners . Angel investors joining the round ... Networks, and Olivier Pomel, CEO at Datadog. This round brings the company’s total funding ...
(Date:2/13/2019)... ... 13, 2019 , ... American Vision Partners, one of the ... a new addition to their growing list of ophthalmology brands: Visage Aesthetics & ... ophthalmology practice. , Dr. Zachary Berbos, MD, FACS, and Dr. Grant ...
(Date:2/13/2019)... ... ... A Place at Home has received the 2019 Best of ... Choice Award is granted only to the top-ranking home care providers, based on caregiver ... care. A Place at Home is ranked among the best employers of in-home caregivers ...
(Date:2/13/2019)... ... 2019 , ... Surgery that moves both jaws forward – known as maxillomandibular ... (OSA), resulting in benefits that include improved breathing, daytime wakefulness and quality of life, ... should be regarded as the preferred treatment for patients with moderate to severe OSA ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... ... February 14, 2019 , ... San ... UroLift® Center of Excellence. The designation recognizes that Dr. Peterson has achieved a ... commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic ...
(Date:2/13/2019)... ... February 14, 2019 , ... Entomol’s ... approval by the California EPA for release and sale within the state. California ... major milestone in Entomol‘s commercial development. This registration opens the door for wholesale/retail ...
(Date:2/13/2019)... ... 13, 2019 , ... NCPDP announced today that Jim Carroll, ... Wednesday, May 8, at its 2019 Annual Technology & Business Conference. Themed Dare ... Spa in Scottsdale, Arizona, and is expected to draw more than 700 attendees ...
Breaking Medicine Technology: